Public Health England
On 8 December 2020, the UK became the first country to roll out a COVID-19 vaccination programme, initially using the Pfizer/BioNTech vaccine.
Since the beginning of the programme, Public Health England has been monitoring the effectiveness of the vaccines in the real world and has now published its first analysis of the impact of the Pfizer/BioNTech vaccine on:
- symptomatic disease
- infection (symptomatic or asymptomatic)